In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is down 1% to 5,649 points after tensions in North Korea rose.
Four shares which have fallen more than most today are listed below. Here’s what sent them lower:
The Asaleo Care Ltd (ASX: AHY) share price is down 3% to $1.52 today. Although the personal care company delivered a reasonably mixed full-year result last week, today’s decline is largely attributable to its shares going ex-dividend today. Asaleo Care’s final partially franked 4 cents per share dividend will be paid to shareholders on September 21.
The Bubs Australia Ltd (ASX: BUB) share price has fallen almost 10% to 61.5 cents following the release of its full-year result after the market closed yesterday. In FY 2017 Bubs posted a statutory loss before tax of $5 million. Whilst the infant formula and baby food company has had a strong start to FY 2018, its unaudited revenue growth of 110% year-to-date appears to have disappointed the market.
The Nanosonics Ltd. (ASX: NAN) share price is down 5% to $2.44. I feel today’s decline is likely to be a spot of profit taking after its shares surged significantly higher over the last two trading days. This could arguably be a great opportunity to snap up the shares of the infection control specialist.
The Mesoblast limited (ASX: MSB) share price has fallen almost 12% to $1.42. Today’s decline comes after the cell-based medicine developer’s shares returned to trade following the announcement of a fully underwritten $50.7 million entitlement offer at $1.40 per share. Management believes the newly invested capital will provide Mesoblast with the balance sheet flexibility required to achieve its near-term corporate objectives.
If your portfolio took a hit today don't worry. These shares could be just what it needs to take it higher again.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.